Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 6 | $2,855,122 |
| Sells | 5 | $57,808 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 31 Jul 2024 16:19 | ADVM | Adverum Biotechnologies Inc | LEONARD BRADEN MICHAEL | 10% | 30 Jul 2024 | Purchase | 85,800 | 7.15 | 613,470 | I |
| 18 Jul 2024 21:16 | ADVM | Adverum Biotechnologies Inc | LEONARD BRADEN MICHAEL | 10% | 18 Jul 2024 | Purchase | 80,718 | 9.1149 | 735,736 | I |
| 18 Jul 2024 21:16 | ADVM | Adverum Biotechnologies Inc | LEONARD BRADEN MICHAEL | 10% | 17 Jul 2024 | Purchase | 135,546 | 7.7459 | 1,049,926 | I |
| 09 Feb 2024 17:51 | ADVM | Adverum Biotechnologies Inc | SCOPA JAMES PAUL | Director | 07 Feb 2024 | Purchase | 100,000 | 1.35 | 135,000 | D |
| 09 Feb 2024 17:50 | ADVM | Adverum Biotechnologies Inc | LUPHER, JR. MARK L. | Director | 07 Feb 2024 | Purchase | 130,000 | 1.35 | 175,500 | D |
| 18 Sep 2023 18:54 | ADVM | Adverum Biotechnologies Inc | SEYEDKAZEMI SETAREH | Chief Development Officer | 15 Sep 2023 | Sale | 130 | 1.5486 | 201 | D |
| 18 Sep 2023 18:54 | ADVM | Adverum Biotechnologies Inc | SEYEDKAZEMI SETAREH | Chief Development Officer | 15 Sep 2023 | Sale | 6,071 | 1.52 | 9,228 | D |
| 09 Jun 2023 16:26 | ADVM | Adverum Biotechnologies Inc | RUBINSTEIN LINDA M | Chief Financial Officer | 07 Jun 2023 | Purchase | 100,000 | 1.4549 | 145,490 | D |
| 17 Mar 2023 18:02 | ADVM | Adverum Biotechnologies Inc | RILEY BRIGIT | Chief Scientific Officer | 15 Mar 2023 | Sale | 7,299 | 0.7816 | 5,705 | D |
| 17 Mar 2023 18:02 | ADVM | Adverum Biotechnologies Inc | SOPARKAR PETER | Chief Operating Officer | 15 Mar 2023 | Sale | 13,360 | 0.7816 | 10,442 | D |
| 17 Mar 2023 18:01 | ADVM | Adverum Biotechnologies Inc | FISCHER LAURENT | CEO, President and Director | 15 Mar 2023 | Sale | 41,239 | 0.7816 | 32,232 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)